Get the Stockscreener App
3.15
0.63%
-0.02
After Hours:
3.15
Protara Therapeutics Inc stock is traded at $3.15, with a volume of 101.53K.
It is down -0.63% in the last 24 hours and up +0.00% over the past month.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
See More
Previous Close:
$3.17
Open:
$3.2
24h Volume:
101.53K
Relative Volume:
0.36
Market Cap:
$121.53M
Revenue:
-
Net Income/Loss:
$-42.05M
P/E Ratio:
-1.117
EPS:
-2.82
Net Cash Flow:
$-35.26M
1W Performance:
+0.96%
1M Performance:
+0.00%
6M Performance:
-13.22%
1Y Performance:
+65.79%
1-Day Range:
$3.13
$3.29
1-Week Range:
$3.1042
$3.30
52-Week Range:
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Name
Protara Therapeutics Inc
Sector
Industry
Phone
646-844-0337
Address
345 PARK AVENUE SOUTH, NEW YORK, NY
Compare TARA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.15 | 122.30M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-14-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-10-23 | Resumed | Guggenheim | Buy |
| Jun-04-21 | Initiated | H.C. Wainwright | Buy |
| Feb-17-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Jul-29-20 | Initiated | Guggenheim | Buy |
View All
Protara Therapeutics Inc Stock (TARA) Latest News
What data driven models say about Protara Therapeutics Inc.’s futureBear Alert & Comprehensive Market Scan Reports - Newser
Candlestick signals on Protara Therapeutics Inc. stock today2025 Price Targets & Safe Entry Trade Signal Reports - Newser
Full technical analysis of Protara Therapeutics Inc. stockWatch List & High Accuracy Swing Entry Alerts - Newser
Can Protara Therapeutics Inc. ride the EV waveWeekly Trade Recap & Capital Protection Trading Alerts - خودرو بانک
Can Protara Therapeutics Inc. maintain its current growth rateBond Market & Low Drawdown Momentum Trade Ideas - خودرو بانک
Market reaction to Protara Therapeutics Inc.’s recent newsJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - Newser
Should you hold or exit Protara Therapeutics Inc. now2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
Is Protara Therapeutics Inc. stock a good pick for beginnersIndex Update & Safe Capital Growth Stock Tips - خودرو بانک
How to use Fibonacci retracement on Protara Therapeutics Inc.Weekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
What institutional flow reveals about Protara Therapeutics Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
Combining machine learning predictions for Protara Therapeutics Inc.Bull Run & Expert-Curated Trade Recommendations - Newser
Technical signs of recovery in Protara Therapeutics Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
Published on: 2025-09-04 06:47:02 - Newser
Published on: 2025-09-04 03:23:29 - Newser
How to escape a deep drawdown in Protara Therapeutics Inc.Earnings Beat & AI Optimized Trade Strategies - Newser
Using economic indicators to assess Protara Therapeutics Inc. potentialIndex Update & Reliable Price Breakout Alerts - Newser
Using data filters to optimize entry into Protara Therapeutics Inc.New Guidance & Capital Efficiency Focused Strategies - Newser
How Protara Therapeutics Inc. stock performs during market volatilityEarnings Risk Summary & Long-Term Safe Return Strategies - Newser
Protara Therapeutics shares rise 3.79% intraday after announcing inducement grants to new employees. - AInvest
What Fibonacci levels say about Protara Therapeutics Inc. reboundRisk Management & Real-Time Chart Breakout Alerts - Newser
Published on: 2025-09-02 22:40:30 - Newser
Can momentum traders help lift Protara Therapeutics Inc.2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Aug Catalysts: What is Protara Therapeutics Inc.’s TAM (Total Addressable Market)July 2025 Decliners & AI Forecast Swing Trade Picks - خودرو بانک
Protara Therapeutics’ Equity Inducement Grants: A Strategic Catalyst for Talent Retention and Long-Term Value Creation - AInvest
Protara Therapeutics shares fall 1.89% after-hours following inducement grants to new employees. - AInvest
Protara Therapeutics, Inc. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Biotech Firm Protara Therapeutics Issues $3.17/Share Stock Options in Key Employee Compensation Plan - Stock Titan
Published on: 2025-09-02 12:19:22 - Newser
Protara Therapeutics Inc.’s volatility index tracking explainedPortfolio Return Report & AI Powered Trade Plan Recommendations - Newser
Is Protara Therapeutics Inc. vulnerable to short sellers2025 Trading Volume Trends & Intraday High Probability Setup Alerts - خودرو بانک
Is Protara Therapeutics Inc. in a bullish channelTrade Performance Summary & Long-Term Safe Investment Plans - خودرو بانک
What is the earnings history of Protara Therapeutics Inc.2025 Performance Recap & Smart Investment Allocation Tips - خودرو بانک
Published on: 2025-09-02 08:13:43 - خودرو بانک
Is Protara Therapeutics Inc. a top pick in the sectorJuly 2025 Rallies & Expert Approved Momentum Ideas - خودرو بانک
Chartists Watching For Breakout in Protara Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
How to use a screener to detect Protara Therapeutics Inc. breakoutsMarket Activity Recap & Real-Time Volume Analysis - Newser
Protara Therapeutics Inc Stock (TARA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):